The availability of targeted anticancer drugs and the relative affordability of genomic analyses has led to a growing expectation among patients with cancer that they can receive personalized treatment based on the genomic signature of their tumour. Here, we discuss some of the challenges and steps needed to bring such approaches into routine practice.

Additional Metadata
Persistent URL dx.doi.org/10.1038/nrd.2017.218, hdl.handle.net/1765/103840
Journal Nature Reviews Drug Discovery
Rights no subscription
Citation
Salgado, R, Moore, H.M, Martens, J.W.M, Lively, T, Malik, S, McDermott, U, … Lacombe, D. (2018). Steps forward for cancer precision medicine. Nature Reviews Drug Discovery (Vol. 17, pp. 1–2). doi:10.1038/nrd.2017.218